Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04804878 · ClinicalTrials.gov registry record
Morehouse Total Cancer Care Protocol
A clinical trial of Cancer and Cancer Risk, sponsored by Morehouse School of Medicine.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT04804878: Recruiting study of Cancer and Cancer Risk, sponsored by Morehouse School of Medicine.
NCT04804878 is a study of Cancer and Cancer Risk that is actively recruiting participants, run by Morehouse School of Medicine. The registered enrollment target is 5,000 participants, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04804878, a study of Cancer and Cancer Risk, is actively recruiting participants, sponsored by Morehouse School of Medicine.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and "personalized medicine" for our community oncology partners (i.e., community hospital systems, and other cancer care providers). To bring new translational research to the community, Morehouse School of Medicine has initiated the Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of African American cancer patients, survivors, or those at risk of having cancer. This is not a treatment trial, but a longitudinal study designed to create a centralized cancer biorepository for precision medicine.
Primary Outcome
Establish a longitudinal clinical and related data and tissue repository that will contain cancer predisposing risk factors via surveys and questionnaires.
Conditions Studied
Interventions
- OTHER Medical Chart Review
- PROCEDURE Collection of blood, tissue, and other biological samples.
Study Locations (1)
Georgia
- Morehouse School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2018-04-05 |
| Est. Completion | 2037-04 |
What NCT04804878 shows while recruiting
NCT04804878 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT04804878 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04804878 about?
NCT04804878 is a clinical study titled "Morehouse Total Cancer Care Protocol". The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and "personalized medicine" for our community oncology partners (i.e., community hospital ...
What is the current status of trial NCT04804878?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2018-04-05. Estimated completion is 2037-04.
What conditions does trial NCT04804878 study?
This clinical trial studies the following conditions: Cancer, Cancer Risk.
What interventions are being tested in trial NCT04804878?
The interventions under investigation include: Medical Chart Review (OTHER), Collection of blood, tissue, and other biological samples. (PROCEDURE).
Who is sponsoring clinical trial NCT04804878?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04804878 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04804878's enrollment target sits among peer trials
5,000 42nd of 615 higher than 571 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI